In studies of the inter-relationship between intracranial pressure and cerebral blood flow a variety of methods of raising intracranial pressure have been used and the results have been, in quantitative terms, quite variable (Kety et al., 1948; Greenfield and Tindall, 1965; Langfitt et al., 1965; Zwetnow, 1970; Johnston et al., 1972 Johnston et al., , 1973 . Extrapolation from the experimental to the clinical situation is also complicated by the use, in most laboratory studies, of a relatively rapid and progressive rise in intracranial pressure, which contrasts with the episodic and often infrequent rises seen clinically (Lundberg, 1960) . Further, simultaneous recording of arterial and intracranial pressures during plateau waves in patients has shown that marked reductions in cerebral perfusion pressure may occur without any observable adverse effects, in apparent contradiction of most of the experimental results (Miller et al., 1972; Johnston and Paterson, 1974) . Previous studies of cerebral blood flow changes during plateau waves have been entirely clinical, and have suggested that during such waves there is a fall in blood flow but an increase in cerebral blood (Accepted 16 June 1975.) volume (Lundberg et al., 1968; Risberg et al., 1969) .
The aim of the present study was to examine experimentally the effects of episodic increases in intracranial pressure, simulating clinical plateau waves, on cerebral blood flow in primates. Metabolic studies were carried out simultaneously to determine whether changes in perfusion pressure adversely affected brain metabolism independent of changes in cerebral blood flow and also whether metabolic changes might trigger changes in cerebrovascular resistance, which would enable cerebral blood flow to be maintained despite very low perfusion pressures.
METHODS
Five baboons, weighing between 11 and 14 kg, were anaesthetized using phencyclidine hydrochloride (10 mg) and thiopentone sodium (60 mg) for induction and phencyclidine hydrochloride, suxamethonium chloride, and nitrous oxide/oxygen for maintenance. Ventilation was controlled by means of a Starling pump delivering a tidal volume between 150 and 250 ml, adjusted according to arterial blood gas levels. Cannulae were placed in the following sites: 076 1. Left femoral artery, for arterial pressure and intermittent blood gas and metabolite sampling.
2. Superior sagittal sinus, for continuous pressure recording and intermittent blood gas and metabolite sampling.
3. Cisterna magna, for continuous CSF pressure recording and infusion of 'mock' CSF to raise intracranial pressure.
4. Right lateral vZentricle, for continuous intraventricular pressure recording.
5. Right lingual artery, for injection of 133Xenon for cerebral blood flow measurements.
Arterial, sagittal sinus, and intracranial pressures were measured using strain gauge pressure transducers (Bell & Howell) and continuously recorded on paper chart recorders (Devices). Cerebral blood flow was estimated in two ways; (I) by the 133Xenon clearance method, using a slug injection of 0.5 mCi 133Xenon dissolved in 0.45 to 0.55 ml saline, into the lingual artery cannula (external carotid artery ligated); the rate of clearance of gamma activity was measured using a collimated 1.0 inch (2.5 cm) sodiuLm iodide crystal detector placed over the right parietal region; blood flow was calculated from the initial slope and by the height over area method using a 10 minute correction; (2) by an electromagnetic flow probe (Nycotron) on the right common carotid artery (external carotid artery ligated).
End-tidal CO2 was continuously monitored using an infra-red analyser (Capnograph) . Arterial and sagittal sinus pH, PO2 and pCO2 levels, and arterial and sinus oxygen saturations were also measured at frequent intervals, as were arterial packed cell Volume (PCV) and haemoglobin levels.
Blood for metabolic estimations was taken from the femoral artery and the superior sagittal sinlus, the 2.5 ml samples received into ice-cold perchloric acid and the acid extract treated as described by Johnson et al. (1969) . Analyses were carried out for lactate and pyruvate (Hohorst et al., 1959) , acetoacetate and 3-hydroxybutyrate (Williamson et al., 1962) , glucose (Werner et al., 1970) , and glycerol (Kreutz, 1962) . Paired samples were taken during a control cerebral blood flow measurement and during the cerebral blood flow measurements which were carried out at the time of the first, third, and fifth pressure waves (ridle intfra). By reference to the corresponding cerebral blood flow measurements the cerebral uptake and output of metabolites were calculated.
The experimental design was as follows ( Fig. 1 creasing intracranial pressure (Tables la and b) , although the magnitude and timing of the response varied. Two animals showed a marked rise in blood pressure ( > 400/o control) with the initial increase in intracranial pressure, two showed a moderate rise, and one no rise, although this animal did show a marked increase in blood pressure with the second pressure wave. After the initial increase, the blood pressure remained higher than control levels at all times, although the pattern of response to subsequent waves differed. Three animals showed a further increase in blood pressure above the already increased basic level, with each successive wave. In the remaining two animals, the pattern was less clear: in one the blood pressure remained relatively constant after the initial rise and, in the other, the blood pressure fell during pressure waves and rose between them. (Tables la and b ) and, in four cases the increase was substantial. In the majority, the main rise in sagittal sinus pressure started during the third or fourth pressure wave, and, once an increase had occurred, the pressure tended to be higher during than between waves, although this was not invariably so. Mean values showed little difference during and between waves (Tables la and b) . Rhythmic fluctuations in sagittal sinus pressure were also seen, and these were associated with simultaneous changes in intracranial pressure and internal carotid artery blood flow. Overall, no specific relationship was observed between sagittal sinus pressure and cerebral blood flow changes, and normal cerebral blood flow levels could be maintained despite persistently high sinus pressure between waves.
6. CEREBROVASCULAR RESISTANCE Cerebrovascular resistance fell with the initial increase in intracranial pressure in each animal and continued to fall, to a progressively greater extent, during each subsequent wave. Between waves, cerebrovascular resistance tended to return towards control levels, although not reaching these values until the final stages of each experiment. During the hyperaemic phase, cerebro- (Table 3) . DISCUSSION The clinical observation that patients with intracranial hypertension may show severe reduction in cerebral perfusion pressure without any apparent adverse effects (Miller et al., 1972; Johnston and Paterson, 1974 ) is in contrast with experimental findings which would suggest that a progressive reduction of cerebral blood flow should accompany a falling cerebral perfusion pressure once this drops below a critical level (Zwetnow, 1970) . This apparent contradiction raises several important questions. First, does the absence of neurological dysfunction in patients with a seemingly inadequate cerebral perfusion pressure truly reflect relatively normal levels of cerebral blood flow? Second, if adequate cerebral blood flow is being maintained, what is the responsible mechanism, and third, is reversible or irreversible neurological damage resulting from the lowered cerebral perfusion pressure due either to alterations in blood flow or brain metabolism, which is not immediately reflected in the patient's clinical state?
The present experimental findings would suggest that relatively adequate cerebral blood flow levels are maintained during episodic increases in intracranial pressure with corresponding reductions in cerebral perfusion pressure. During the initial moderate increases in intracranial pressure, hyperaemia developed which increased cerebral blood flow by approximately 100% during the periods between pressure waves. The hyperaemia was associated with both an increase in cerebral perfusion pressure and a reduction in cerebral vascular resistance but did not depend on any prior fall in either blood flow or perfusion pressure. Subsequent waves of intracranial pressure did reduce cerebral blood flow, but because of the high levels between waves, flow was maintained at relatively normal levels. Later in the experimental sequence, the hyperaemia between pressure waves diminished, and further pressure waves reduced cerebral blood flow below control levels, although relatively high flows were still maintained despite intracranial pressures exceeding 100 mmHg. The reduction in hyperaemia between waves was due largely to an increase in total vascular resistance, which may in part reflect increasing venous compression.
Does this mechanism operate in the clinical situation? A number of experimental studies have shown that hyperaemia will occur after the release of a sustained increase in intracranial pressure (Hiiggendal et al., 1970 (Johnston et al., 1972 (Johnston et al., , 1973 (Zwetnow, 1970; Johnston et al., 1972 Johnston et al., , 1973 . Why vascular dilatation does occur in these situations remains unknown, reflecting the basic ignorance of the mechanism of control of the calibre of the cerebral vessels-that is, the phenomenon of autoregulation (Green et al., 1963) . The detailed studies of Zwetnow (1970) (EkstromJodal, 1972 ) and the present work, it was clear that a preceding fall in either blood flow or perfusion pressure was not a prerequisite for the development of hyperaemia. Further, there was no consistent metabolic change in the present study which might be held responsible.
The common coincidence of hyperaemia with a blood pressure response and also its occurrence in some instances with intracranial pressure changes alone certainly raises the possibility of a purely myogenic mechanism, based on changes in transmural pressure across the resistance vessels. It is worth noting that cerebral hyperaemia can also occur with spinal cord compression alone, when it is associated with a blood pressure response, good evidence against the primacy of underlying metabolic changes (Rowan and Johnston, 1975) . These findings do not, however, rule out the possibility of a primary neurogenic action on the cerebral vessels, which have been shown to be richly innervated by adrenergic nerve fibres (Nelson and Rennels, 1970) . The intense sympathetic activity associated with the increase in intracranial pressure may thus be reflected in both systemic hypertension and intracranial vascular resistance changes. A complete understanding of the exact mechanism underlying the hyperaemia must, however, await a fuller understanding of the mechanism of auto-regulation in general, although, conversely, studies of hyperaemia may themselves shed some light on the unresolved questions concerning autoregulation.
The question whether such episodic increases in intracranial pressure do, in fact, cause reversible or irreversible damage to brain tissue, even in patients who remain clinically well, has as yet no clear-cut answer. There seems little doubt that metabolic changes in particular do occur, despite maintenance of adequate cerebral blood flow, although whether these result in permanent damage is uncertain. The answer to this critical question must await further studies of blood flow and metabolic changes in patients with plateau waves, as well as further attempts to reproduce the clinical situation in the laboratory.
In conclusion, it seems experimentally that episodic increases in intracranial pressure, simulating clinical plateau waves, cause cerebral hyperaemia, the onset of which does not depend on any consistent preceding changes in cerebral blood flow, cerebral perfusion pressure, or brain metabolism. Hyperaemia is characteristically associated with a blood pressure response, an increase in cerebral perfusion pressure and a fall in cerebral vascular resistance, and might result from intrinsic myogenic or neurogenic in-fluences on the cerebral vessels. Whatever the cause, development of hyperaemia may be the mechanism whereby cerebral blood flow is maintained in patients who show marked reduction in cerebral perfusion pressure during plateau waves. Both this and the question whether such patients actually suffer occult changes in brain blood flow and metabolism must, however, await further clinical studies.
